Logo image of AKU

AKUMIN INC (AKU) Stock Fundamental Analysis

NASDAQ:AKU - US01021X1000 - Common Stock

0.2887 USD
-0.06 (-17.87%)
Last: 10/25/2023, 8:00:00 PM
0.2875 USD
0 (-0.42%)
After Hours: 10/25/2023, 8:00:00 PM
Fundamental Rating

3

AKU gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 104 industry peers in the Health Care Providers & Services industry. AKU may be in some trouble as it scores bad on both profitability and health. AKU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year AKU has reported negative net income.
In the past year AKU had a positive cash flow from operations.
In the past 5 years AKU reported 4 times negative net income.
In the past 5 years AKU always reported a positive cash flow from operatings.
AKU Yearly Net Income VS EBIT VS OCF VS FCFAKU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M -100M -150M

1.2 Ratios

AKU has a Return On Assets of -9.35%. This is in the lower half of the industry: AKU underperforms 66.96% of its industry peers.
AKU's Return On Invested Capital of 2.58% is in line compared to the rest of the industry. AKU outperforms 53.91% of its industry peers.
AKU had an Average Return On Invested Capital over the past 3 years of 1.89%. This is significantly below the industry average of 9.61%.
The 3 year average ROIC (1.89%) for AKU is below the current ROIC(2.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.35%
ROE N/A
ROIC 2.58%
ROA(3y)-5.55%
ROA(5y)-3.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.89%
ROIC(5y)2.77%
AKU Yearly ROA, ROE, ROICAKU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 100 200 300

1.3 Margins

Looking at the Operating Margin, with a value of 6.78%, AKU is in the better half of the industry, outperforming 72.17% of the companies in the same industry.
AKU's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 25.32%, AKU is in line with its industry, outperforming 49.57% of the companies in the same industry.
AKU's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.78%
PM (TTM) N/A
GM 25.32%
OM growth 3Y9.52%
OM growth 5Y35.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.3%
GM growth 5Y-16.74%
AKU Yearly Profit, Operating, Gross MarginsAKU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

AKU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AKU has been increased compared to 1 year ago.
The debt/assets ratio for AKU is higher compared to a year ago.
AKU Yearly Shares OutstandingAKU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
AKU Yearly Total Debt VS Total AssetsAKU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

2.2 Solvency

AKU has an Altman-Z score of 0.30. This is a bad value and indicates that AKU is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AKU (0.30) is worse than 66.96% of its industry peers.
AKU has a debt to FCF ratio of 59.58. This is a negative value and a sign of low solvency as AKU would need 59.58 years to pay back of all of its debts.
With a Debt to FCF ratio value of 59.58, AKU perfoms like the industry average, outperforming 46.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 59.58
Altman-Z 0.3
ROIC/WACC0.59
WACC4.35%
AKU Yearly LT Debt VS Equity VS FCFAKU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.09 indicates that AKU should not have too much problems paying its short term obligations.
With a Current ratio value of 1.09, AKU is not doing good in the industry: 70.43% of the companies in the same industry are doing better.
AKU has a Quick Ratio of 1.09. This is a normal value and indicates that AKU is financially healthy and should not expect problems in meeting its short term obligations.
AKU's Quick ratio of 1.09 is on the low side compared to the rest of the industry. AKU is outperformed by 61.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
AKU Yearly Current Assets VS Current LiabilitesAKU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for AKU have decreased strongly by -118.41% in the last year.
Looking at the last year, AKU shows a very strong growth in Revenue. The Revenue has grown by 38.20%.
AKU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 59.26% yearly.
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.13%
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y59.26%
Sales Q2Q%0.71%

3.2 Future

AKU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.98% yearly.
The Revenue is expected to grow by 5.00% on average over the next years.
EPS Next Y45.08%
EPS Next 2Y29.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AKU Yearly Revenue VS EstimatesAKU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
AKU Yearly EPS VS EstimatesAKU Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AKU. In the last year negative earnings were reported.
Also next year AKU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AKU Price Earnings VS Forward Price EarningsAKU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AKU is valued cheaper than 81.74% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKU indicates a rather cheap valuation: AKU is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.18
EV/EBITDA 8.75
AKU Per share dataAKU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

AKU's earnings are expected to grow with 29.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.98%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AKU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKUMIN INC

NASDAQ:AKU (10/25/2023, 8:00:00 PM)

After market: 0.2875 0 (-0.42%)

0.2887

-0.06 (-17.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-09 2023-08-09
Earnings (Next)11-07 2023-11-07
Inst Owners0%
Inst Owner Change0%
Ins Owners15.75%
Ins Owner Change0%
Market Cap25.84M
Analysts45
Price Target0.92 (218.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-60.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 1.18
P/OCF 0.44
P/B N/A
P/tB N/A
EV/EBITDA 8.75
EPS(TTM)-1.8
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)0.25
FCFY84.98%
OCF(TTM)0.66
OCFY229.66%
SpS8.39
BVpS-0.93
TBVpS-13.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.35%
ROE N/A
ROCE 3.26%
ROIC 2.58%
ROICexc 2.65%
ROICexgc 11.22%
OM 6.78%
PM (TTM) N/A
GM 25.32%
FCFM 2.92%
ROA(3y)-5.55%
ROA(5y)-3.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.89%
ROIC(5y)2.77%
ROICexc(3y)1.99%
ROICexc(5y)2.97%
ROICexgc(3y)6.74%
ROICexgc(5y)9.33%
ROCE(3y)2.39%
ROCE(5y)3.5%
ROICexcg growth 3Y33.83%
ROICexcg growth 5Y32.54%
ROICexc growth 3Y18.03%
ROICexc growth 5Y32.94%
OM growth 3Y9.52%
OM growth 5Y35.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.3%
GM growth 5Y-16.74%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 59.58
Debt/EBITDA 8.69
Cap/Depr 38.76%
Cap/Sales 4.98%
Interest Coverage 0.76
Cash Conversion 40.27%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 0.3
F-Score4
WACC4.35%
ROIC/WACC0.59
Cap/Depr(3y)38.9%
Cap/Depr(5y)51.85%
Cap/Sales(3y)4.13%
Cap/Sales(5y)4.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.13%
EPS Next Y45.08%
EPS Next 2Y29.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y59.26%
Sales Q2Q%0.71%
Revenue Next Year3.13%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y270.48%
EBIT growth 3Y64.54%
EBIT growth 5Y115.95%
EBIT Next Year262.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.58%
FCF growth 3Y436.48%
FCF growth 5YN/A
OCF growth 1Y59.77%
OCF growth 3Y121.33%
OCF growth 5Y94.79%